US HB5763 | 2015-2016 | 114th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on July 13 2016 - 25% progression, died in committee
Action: 2016-08-01 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on July 13 2016 - 25% progression, died in committee
Action: 2016-08-01 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Prostate Cancer Misdiagnosis Elimination Act of 2016 This bill specifies that, unless the physician ordering a DNA Specimen Provenance Assay (DSPA) test recommends otherwise, a DSPA test furnished with respect to a positive prostate cancer biopsy shall be deemed to be medically necessary for purposes of Medicare.
Title
Prostate Cancer Misdiagnosis Elimination Act of 2016
Sponsors
| Rep. Larry Bucshon [R-IN] | Rep. Donald Payne [D-NJ] | Rep. Andre Carson [D-IN] | Sen. Markwayne Mullin [R-OK] |
History
| Date | Chamber | Action |
|---|---|---|
| 2016-08-01 | House | Referred to the Subcommittee on Health. |
| 2016-07-13 | House | Referred to House Ways and Means |
| 2016-07-13 | House | Referred to House Energy and Commerce |
| 2016-07-13 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2016-07-13 | House | Introduced in House |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/114th-congress/house-bill/5763/all-info |
| Text | https://www.congress.gov/114/bills/hr5763/BILLS-114hr5763ih.pdf |
